Mk. Sun et al., CARDIOVASCULAR-RESPONSES TO AGMATINE, A CLONIDINE-DISPLACING SUBSTANCE, IN ANESTHETIZED RAT, Clinical and experimental hypertension, 17(1-2), 1995, pp. 115-128
Citations number
18
Categorie Soggetti
Pharmacology & Pharmacy","Cardiac & Cardiovascular System
We investigated the cardiovascular responses in anesthetized ventilate
d rats to agmatine (decarboxylated arginine), an amine which is an end
ogenous clonidine-displacing substance (CDS) synthesized in brain. Int
racisternal agmatine dose-dependently increased sympathetic nerve acti
vity and arterial pressure (at 400 nmol by 8.7+/-2.1 mu V and 28.6+/-2
.7 mmHg, respectively) and blocked arterial baroreflex reflexes. Micro
injection of agmatine into the rostral ventrolateral medulla (RVL) had
no effect on arterial pressure or sympathetic nerve activity while io
ntophoresis of agmatine onto defined vasomotor neurons of RVL was also
without effect. Agmatine (i.v.) decreased sympathetic nerve activity
and arterial pressure probably by blocking the transmission through sy
mpathetic ganglia and by direct dilation of vascular smooth muscles. D
espite binding like clonidine to alpha(2)-adrenergic receptors and imi
dazoline (I)-receptors of both classes, agmatine does not replicate th
e central or peripheral actions of clonidine. The results suggest that
earlier cardiovascular actions of partially purified CDS were either
attributable to contaminating molecules and/or that CDS may be a famil
y of molecules.